Advanced Metastatic Pancreatic Cancer
Oncology·MeSH: Pancreatic Neoplasms
Prevalence
8.0 / 100K
Incidence
13.1 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
Frequently asked questions
How many drugs are in development for Advanced Metastatic Pancreatic Cancer?
BioSniper tracks 1 drug in development for Advanced Metastatic Pancreatic Cancer across 1 company.
How many clinical trials target Advanced Metastatic Pancreatic Cancer?
There are 1 clinical trial targeting Advanced Metastatic Pancreatic Cancer tracked by BioSniper.
What is the prevalence of Advanced Metastatic Pancreatic Cancer?
The estimated prevalence of Advanced Metastatic Pancreatic Cancer is approximately 8.0 per 100,000 population.
Deep-dive into Advanced Metastatic Pancreatic Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis